CLYM · Climb Bio, Inc.

$12.11 -0.18 (-1.46%) At close · Jul 29

Market Cap

$703.73M

57.26M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Aoife Brennan	CEO	$669,500	—	—	$1,833,675	$405,048	$14,000	$2,922,223
Perrin Wilson	Chief Business Officer	$406,875	—	—	$794,400	$228,261	$107,831	$1,537,367
Brett Kaplan	COO	$223,608	—	—	$797,250	—	$140,870	$1,161,728
Susan Altschuller	CFO	$127,500	—	—	$963,060	$56,562	$4,250	$1,151,372

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Aoife Brennan	CEO	$330,000	—	$2,070,750	$3,410,550	$181,500	$27,092	$6,019,892
Brett Kaplan	COO	$176,282	—	$461,125	$2,272,734	$79,327	—	$2,989,468
Chief Operating	Officer	$176,282	—	$461,125	$2,272,734	$79,327	—	$2,989,468
Valerie Morisset	Executive Vice President, Research and Development and Chief Scientific Officer	$358,066	$268,550	$169,111	$394,493	—	$1,045,075	$2,235,295
Andrew Levin	Executive Chairman of the Board of Directors	—	—	—	$63,622	—	$60,583	$124,205

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Valerie Morisset	Executive Vice President, Research and Development and Chief Scientific Officer	$510,853	$261,323	—	—	$255,723	$49,721	$1,077,620
Andrew Levin	Executive Chairman of the Board of Directors	—	—	—	$22,522	—	$65,387	$87,909

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Azelby	President, Chief Executive Officer and Director of Eliem	$675,000	$438,750	—	$4,035,050	—	$12,200	$5,161,000
Erin M. Lavelle	Executive Vice President, Chief Operating Officer and Chief Financial Officer	$465,750	$209,588	—	$1,371,917	—	$12,200	$2,059,455
Valerie Morisset	Executive Vice President, Research and Development and Chief Scientific Officer	$399,916	$179,962	—	$1,371,917	—	$37,987	$1,989,782

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Azelby	President, Chief Executive Officer and Director of Eliem	$600,000	$330,000	—	$6,213,187	—	$11,600	$7,154,787
Erin M. Lavelle	Executive Vice President, Chief Operating Officer and Chief Financial Officer	$450,000	$222,750	—	$1,863,975	—	$9,038	$2,545,744
Valerie Morisset	Executive Vice President, Research and Development and Chief Scientific Officer	$347,133	$171,830	—	$1,968,404	—	$38,354	$2,525,721

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Valerie Morisset	Executive Vice President, Research and Development and Chief Scientific Officer	$324,128	$141,561	—	$408,223	—	$31,458	$905,460
Robert Azelby	President, Chief Executive Officer and Director of Eliem	$150,000	$75,000	—	—	—	$3,000	$228,000
Erin M. Lavelle	Executive Vice President, Chief Operating Officer and Chief Financial Officer	$112,500	$50,625	—	—	—	$2,250	$163,375

Executive changes

Person	Role	Change	Effective	Filed
Breanna O’Reilly, Ph.D.	member of the Board	Appointed	2026-06-29	2026-07-01
Douglas Williams	Director	Appointed	2026-06-05	2026-06-08
Alexander (Bo) Cumbo	Director	Appointed	2026-06-05	2026-06-08
Susan Altschuller	principal accounting officer	Appointed	2026-04-30	2026-04-03

Key facts CIK 1768446 CUSIP 28658R106 13F (30d) 10 filings 10 filers Visit website Investor relations